Tapewire

Nasdaq · USD

LGND

LIGAND PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
3825
SEC CIK
0000886163
Parsed reports
442

Last 12 months

Inside the activity.

0 purchase rows · 131 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202508
Dec 202508
Jan 202605
Feb 202605
Mar 2026032
Apr 2026011
May 2026014
Jun 2026016
Jul 202608
Aug 2026012
Sep 202606
Oct 202606

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 01, 2026 Filed Jul 6, 2026 21:11 UTC
Reardon AndrewCLO & Secretary
Exercise / conversionCommon Stock 5,000 $52.27 $261,350.00
Disclosure

SEC source: 0002001011-26-000108 · edgardoc.xml · nonDerivative · entry 2

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,514

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

Read SEC document
June 30, 2026 Filed Jul 6, 2026 21:11 UTC
Reardon AndrewCLO & Secretary
OtherCommon Stock 132 $160.71 $21,213.65
Disclosure

SEC source: 0002001011-26-000108 · edgardoc.xml · nonDerivative · entry 1

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,514

F1 · kind: These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 30, 2026 Filed Jul 6, 2026 21:11 UTC
Espinoza OctavioChief Financial Officer
OtherCommon Stock 17 $160.71 $2,732.06
Disclosure

SEC source: 0002001011-26-000107 · edgardoc.xml · nonDerivative · entry 1

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,696

F1 · kind: These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 30, 2026 Filed Jul 6, 2026 21:10 UTC
Davis Todd CDirector · Chief Executive Officer
OtherCommon Stock 132 $160.71 $21,213.65
Disclosure

SEC source: 0002001011-26-000106 · edgardoc.xml · nonDerivative · entry 1

Davis Todd C · CIK 0001392029 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 199,513

F1 · kind: These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 16, 2026 Filed Jun 18, 2026 12:37 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 2,145 $0.00 Strike: $66.13 $0.00
Disclosure

SEC source: 0001104659-26-075456 · tm2618247-1_4seq1.xml · derivative · entry 3

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,145 shares

Expires 2027-05-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These securities, as represented in Column 5, were acquired by a grant of 2,456 shares approved by the Board of Directors of the Company at the 2017 Meeting, as previously reported on the Reporting Person's Form 4, dated 30 May 2017. That grant vested in full on the first anniversary of the grant date or immediately (x) upon a change in control or a hostile takeover of the Company or (y) the death or permanent disability of the grantee if still serving at that time. The original grant was adjusted to 2,145 shares and the exercise price adjusted to $66.13 pursuant to the OmniAb Inc. separation from the Company.

F2 · derivative.exercise_date: These securities, as represented in Column 5, were acquired by a grant of 2,456 shares approved by the Board of Directors of the Company at the 2017 Meeting, as previously reported on the Reporting Person's Form 4, dated 30 May 2017. That grant vested in full on the first anniversary of the grant date or immediately (x) upon a change in control or a hostile takeover of the Company or (y) the death or permanent disability of the grantee if still serving at that time. The original grant was adjusted to 2,145 shares and the exercise price adjusted to $66.13 pursuant to the OmniAb Inc. separation from the Company.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 12:37 UTC SaleCommon Stock 2,145 $254.00 $544,830.00
Disclosure

SEC source: 0001104659-26-075456 · tm2618247-1_4seq1.xml · nonDerivative · entry 2

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,629

F1 · security: These securities, as represented in Column 5, include the grant of 836 restricted shares approved by the Board of Directors of the Company at the 2026 Meeting held 5 June 2026, which shares were previously reported on a Form 4 for this Reporting Person dated 9 June 2026.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 12:37 UTC Exercise / conversionCommon Stock 2,145 $66.13 $141,848.85
Disclosure

SEC source: 0001104659-26-075456 · tm2618247-1_4seq1.xml · nonDerivative · entry 1

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,774

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities, as represented in Column 5, include the grant of 836 restricted shares approved by the Board of Directors of the Company at the 2026 Meeting held 5 June 2026, which shares were previously reported on a Form 4 for this Reporting Person dated 9 June 2026.

Read SEC document
June 12, 2026 Filed Jun 16, 2026 01:06 UTC
Haas JasonDirector
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 1,000 $0.00 Strike: $51.56 $0.00
Disclosure

SEC source: 0002001011-26-000104 · edgardoc.xml · derivative · entry 6

Haas Jason · CIK 0001883821 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,138

Underlying: Common Stock · 1,000 shares

Expires 2032-06-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This Option was previously reported as a Grant of 5,907 shares on June 29, 2022, at an exercise price of $88.48 per share, which becomes exercisable in three successive annual installments upon completion of each calendar year of service beginning on the grant date, but was adjusted pursuant to the OmniAb Inc. separation from the issuer.

Read SEC document
June 12, 2026 Filed Jun 16, 2026 01:06 UTC
Haas JasonDirector
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 3,000 $0.00 Strike: $51.56 $0.00
Disclosure

SEC source: 0002001011-26-000104 · edgardoc.xml · derivative · entry 5

Haas Jason · CIK 0001883821 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,138

Underlying: Common Stock · 3,000 shares

Expires 2032-06-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This Option was previously reported as a Grant of 5,907 shares on June 29, 2022, at an exercise price of $88.48 per share, which becomes exercisable in three successive annual installments upon completion of each calendar year of service beginning on the grant date, but was adjusted pursuant to the OmniAb Inc. separation from the issuer.

Read SEC document
June 12, 2026 Filed Jun 16, 2026 01:06 UTC
Haas JasonDirector
SaleCommon Stock 3,461 $256.08 $886,286.30
Disclosure

SEC source: 0002001011-26-000104 · edgardoc.xml · nonDerivative · entry 4

Haas Jason · CIK 0001883821 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,981

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $256.0000 to $256.5100. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 12, 2026 Filed Jun 16, 2026 01:06 UTC
Haas JasonDirector
SaleCommon Stock 3,000 $255.01 $765,033.90
Disclosure

SEC source: 0002001011-26-000104 · edgardoc.xml · nonDerivative · entry 3

Haas Jason · CIK 0001883821 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,442

F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $255.0000 to $255.2900. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 12, 2026 Filed Jun 16, 2026 01:06 UTC
Haas JasonDirector
Exercise / conversionCommon Stock 1,000 $51.56 $51,560.00
Disclosure

SEC source: 0002001011-26-000104 · edgardoc.xml · nonDerivative · entry 2

Haas Jason · CIK 0001883821 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,442

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 12, 2026 Filed Jun 16, 2026 01:06 UTC
Haas JasonDirector
Exercise / conversionCommon Stock 3,000 $51.56 $154,680.00
Disclosure

SEC source: 0002001011-26-000104 · edgardoc.xml · nonDerivative · entry 1

Haas Jason · CIK 0001883821 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,442

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 11, 2026 Filed Jun 12, 2026 21:27 UTC
Aryeh JasonDirector
SaleCommon Stock 4,500 $250.00 $1,125,000.00
Disclosure

SEC source: 0002001011-26-000103 · edgardoc.xml · nonDerivative · entry 3

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,580

Read SEC document
June 10, 2026 Filed Jun 12, 2026 21:27 UTC
Aryeh JasonDirector
SaleCommon Stock 500 $250.00 $125,000.00
Disclosure

SEC source: 0002001011-26-000103 · edgardoc.xml · nonDerivative · entry 2

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,080

Read SEC document
June 10, 2026 Filed Jun 12, 2026 21:26 UTC SaleCommon Stock 3,405 $251.62 $856,751.80
Disclosure

SEC source: 0002001011-26-000102 · edgardoc.xml · nonDerivative · entry 4

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,969

F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $250.9100 to $251.8950. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 10, 2026 Filed Jun 12, 2026 21:26 UTC SaleCommon Stock 697 $249.53 $173,924.22
Disclosure

SEC source: 0002001011-26-000102 · edgardoc.xml · nonDerivative · entry 3

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,374

F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $249.3400 to $250.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 10, 2026 Filed Jun 12, 2026 21:26 UTC SaleCommon Stock 232 $248.11 $57,561.78
Disclosure

SEC source: 0002001011-26-000102 · edgardoc.xml · nonDerivative · entry 2

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,071

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $247.9400 to $248.3350. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 10, 2026 Filed Jun 12, 2026 21:26 UTC SaleCommon Stock 257 $247.22 $63,536.49
Disclosure

SEC source: 0002001011-26-000102 · edgardoc.xml · nonDerivative · entry 1

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,303

F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $246.6300 to $247.6100. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 23:42 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 2,938 $0.00 Strike: $237.00 $0.00
Disclosure

SEC source: 0002001011-26-000101 · edgardoc.xml · derivative · entry 3

Zimmermann Martine · CIK 0001994049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,938

Underlying: Common Stock · 2,938 shares

Expires 2036-06-05

F3 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 23:42 UTC Tax withholdingCommon Stock 182 $237.00 $43,134.00
Disclosure

SEC source: 0002001011-26-000101 · edgardoc.xml · nonDerivative · entry 2

Zimmermann Martine · CIK 0001994049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,097

F2 · shares: Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 23:42 UTC GrantCommon Stock 836 $0.00 $0.00
Disclosure

SEC source: 0002001011-26-000101 · edgardoc.xml · nonDerivative · entry 1

Zimmermann Martine · CIK 0001994049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,279

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 23:41 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 2,938 $0.00 Strike: $237.00 $0.00
Disclosure

SEC source: 0002001011-26-000100 · edgardoc.xml · derivative · entry 2

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,938

Underlying: Common Stock · 2,938 shares

Expires 2036-06-05

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 23:41 UTC GrantCommon Stock 836 $0.00 $0.00
Disclosure

SEC source: 0002001011-26-000100 · edgardoc.xml · nonDerivative · entry 1

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,629

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 23:41 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 2,938 $0.00 Strike: $237.00 $0.00
Disclosure

SEC source: 0002001011-26-000099 · edgardoc.xml · derivative · entry 2

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,938

Underlying: Common Stock · 2,938 shares

Expires 2036-06-05

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 23:41 UTC GrantCommon Stock 836 $0.00 $0.00
Disclosure

SEC source: 0002001011-26-000099 · edgardoc.xml · nonDerivative · entry 1

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,560

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 23:40 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 2,938 $0.00 Strike: $237.00 $0.00
Disclosure

SEC source: 0002001011-26-000098 · edgardoc.xml · derivative · entry 2

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,938

Underlying: Common Stock · 2,938 shares

Expires 2036-06-05

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 23:40 UTC GrantCommon Stock 836 $0.00 $0.00
Disclosure

SEC source: 0002001011-26-000098 · edgardoc.xml · nonDerivative · entry 1

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,622

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 23:35 UTC
Haas JasonDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 2,938 $0.00 Strike: $237.00 $0.00
Disclosure

SEC source: 0002001011-26-000097 · edgardoc.xml · derivative · entry 2

Haas Jason · CIK 0001883821 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,938

Underlying: Common Stock · 2,938 shares

Expires 2036-06-05

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 23:35 UTC
Haas JasonDirector
GrantCommon Stock 836 $0.00 $0.00
Disclosure

SEC source: 0002001011-26-000097 · edgardoc.xml · nonDerivative · entry 1

Haas Jason · CIK 0001883821 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,442

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 23:35 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 2,938 $0.00 Strike: $237.00 $0.00
Disclosure

SEC source: 0002001011-26-000096 · edgardoc.xml · derivative · entry 2

Gray Nancy Ryan · CIK 0001714949 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,938

Underlying: Common Stock · 2,938 shares

Expires 2036-06-05

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 23:35 UTC GrantCommon Stock 836 $0.00 $0.00
Disclosure

SEC source: 0002001011-26-000096 · edgardoc.xml · nonDerivative · entry 1

Gray Nancy Ryan · CIK 0001714949 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,930

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 05, 2026 Filed Jun 12, 2026 21:27 UTC
Aryeh JasonDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 2,938 $0.00 Strike: $237.00 $0.00
Disclosure

SEC source: 0002001011-26-000103 · edgardoc.xml · derivative · entry 5

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,938

Underlying: Common Stock · 2,938 shares

Expires 2036-06-05

F4 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 05, 2026 Filed Jun 12, 2026 21:27 UTC
Aryeh JasonDirector
GrantCommon Stock 836 $0.00 $0.00
Disclosure

SEC source: 0002001011-26-000103 · edgardoc.xml · nonDerivative · entry 1

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,580

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

F2 · balance_after: The total number of shares owned has been reduced by 7,825 shares to reflect a reallocation of the reporting person's shares in accordance with his account records.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 22:22 UTC
Reardon AndrewCLO & Secretary
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $52.27 $0.00
Disclosure

SEC source: 0002001011-26-000083 · edgardoc.xml · derivative · entry 9

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,444

Underlying: Common Stock · 5,000 shares

Expires 2032-08-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F8 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on February 1, 2023, and in 42 substantially equal monthly installments thereafter.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 22:22 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 200 $230.41 $46,082.00
Disclosure

SEC source: 0002001011-26-000083 · edgardoc.xml · nonDerivative · entry 8

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,382

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 22:22 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 1,216 $229.47 $279,032.60
Disclosure

SEC source: 0002001011-26-000083 · edgardoc.xml · nonDerivative · entry 7

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,582

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F7 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $229.0900 to $230.0000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 22:22 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 584 $228.57 $133,487.10
Disclosure

SEC source: 0002001011-26-000083 · edgardoc.xml · nonDerivative · entry 6

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,798

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F6 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $228.0500 to $228.9650. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 22:22 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 400 $226.78 $90,711.76
Disclosure

SEC source: 0002001011-26-000083 · edgardoc.xml · nonDerivative · entry 5

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,382

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F5 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $226.5250 to $227.0100. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 22:22 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 1,432 $225.97 $323,585.03
Disclosure

SEC source: 0002001011-26-000083 · edgardoc.xml · nonDerivative · entry 4

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,782

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $225.5200 to $226.3700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 22:22 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 677 $225.20 $152,459.25
Disclosure

SEC source: 0002001011-26-000083 · edgardoc.xml · nonDerivative · entry 3

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 45,214

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $224.5100 to $225.4600. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 22:22 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 491 $223.95 $109,957.83
Disclosure

SEC source: 0002001011-26-000083 · edgardoc.xml · nonDerivative · entry 2

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 45,891

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $223.4250 to $224.3800. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 22:22 UTC
Reardon AndrewCLO & Secretary
Exercise / conversionCommon Stock 5,000 $52.27 $261,350.00
Disclosure

SEC source: 0002001011-26-000083 · edgardoc.xml · nonDerivative · entry 1

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,382

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.

Read SEC document
May 27, 2026 Filed May 28, 2026 23:43 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 764 $0.00 Strike: $63.62 $0.00
Disclosure

SEC source: 0002001011-26-000071 · edgardoc.xml · derivative · entry 4

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,407

Underlying: Common Stock · 764 shares

Expires 2032-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Grant to reporting person of stock options that will vest and become exercisable over a 4-year period measured from December 5, 2022, with 12-1/2% of the shares subject to the stock options vesting on the date that is six months after December 5, 2022 and the remaining stock options vesting in 42 equal monthly installments thereafter.

Read SEC document
May 27, 2026 Filed May 28, 2026 23:43 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 972 $0.00 Strike: $52.84 $0.00
Disclosure

SEC source: 0002001011-26-000071 · edgardoc.xml · derivative · entry 3

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 972 shares

Expires 2032-05-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock option vests as to approximately 55% of the underlying shares in 12 substantially equal monthly installments beginning on January 5, 2025, and approximately 45% of the underlying shares in two substantially equal monthly installments thereafter.

Read SEC document
May 27, 2026 Filed May 28, 2026 23:43 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionCommon Stock 972 $52.84 $51,360.48
Disclosure

SEC source: 0002001011-26-000071 · edgardoc.xml · nonDerivative · entry 2

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,679

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 27, 2026 Filed May 28, 2026 23:43 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionCommon Stock 764 $63.62 $48,605.68
Disclosure

SEC source: 0002001011-26-000071 · edgardoc.xml · nonDerivative · entry 1

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,707

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 13, 2026 Filed May 15, 2026 01:08 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 1,575 $0.00 Strike: $69.51 $0.00
Disclosure

SEC source: 0002001011-26-000049 · edgardoc.xml · derivative · entry 11

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,575 shares

Expires 2026-05-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: This Option was previously reported as a Grant of 2,329 shares, which vested in full on May 23, 2017, at an exercise price of $119.3000 per share but was adjusted pursuant to the OmniAb Inc. separation from the issuer.

Read SEC document
May 13, 2026 Filed May 15, 2026 01:08 UTC SaleCommon Stock 1,575 $223.50 $352,012.50
Disclosure

SEC source: 0002001011-26-000049 · edgardoc.xml · nonDerivative · entry 9

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,786

Read SEC document
May 13, 2026 Filed May 15, 2026 01:08 UTC Exercise / conversionCommon Stock 1,575 $69.51 $109,478.25
Disclosure

SEC source: 0002001011-26-000049 · edgardoc.xml · nonDerivative · entry 8

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,361

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.